During this webinar, panelists will discuss how to leverage your IP rights to assist in stopping illicit trade.

This webinar will explore various issues around the current hot topic of different work models and their impact on lawyers, law firms, and in-house legal departments. In particular, this webinar will include a robust discussion around the mental health impact on lawyers; the DEI impact on lawyers, law firms, and in-house legal departments; and the various pros and cons of lawyers working remotely, in a hybrid model, or 100% in-office. *CLE Note* VA has approved this course for 0.5 Well-Being credit & IL has approved this course for 0.25 Diversity & Inclusion Credit and 0.25 Mental Health and Substance Abuse credit.

This webinar will feature a panel of who’s who of PTAB judges who will address many issues involving AIA proceedings. Whether you represent patent owners or petitioners you will want to attend the program. The judges will address the perceived success rates of petitioners, motions to amend, serial and parallel proceedings, use of secondary considerations evidence, proper use of expert testimony, Sotera stipulations, real parties in interest, discovery requests, Director review and more. The panel will also provide an update on proposed rule changes as well as dos and don’ts of brief writing and oral argument. *PLEASE NOTE that This webinar does not qualify for CLE.*

This webinar will provide a recap of many of the key trademark cases from the Trademark Trial and Appeal Board and the Federal Circuit in 2023, highlighting decisions regarding failure to function as a trademark, use in commerce, standing, and more.

This webinar will address major relevant developments in generative artificial intelligence, such as ChatGPT, as related to patent prosecution. The panel will discuss some recent takeaways from case law, developments in AI tools, and practice tips for attorneys looking to begin implementing AI tools in their everyday work. In particular, the panel will continue a discussion started at the IPO Annual Meeting regarding the proper role of generative AI in prosecution, as opposed to “classic” AI approaches or human drafting.

This webinar will explore the evolving landscape of pharmaceutical patents, focusing on key issues facing the industry. Topics include emerging jurisprudence concerning induced infringement based on prescribing information, and challenges and strategies related to validity, including written description, enablement, and obviousness. Additionally, speakers will examine the latest USPTO guidance concerning the intersection of inventorship and AI, and delve into issues impacting patent term, in particular double patenting and continuation practice. Finally, panelists will provide an update on issues to be aware of concerning listing patents in FDA’s Orange Book.

On February 5, an en banc Federal Circuit will consider whether the current design patent obviousness test is overly rigid and should be revised. The Court has issued a series of detailed questions to be considered and this forthcoming decision could fundamentally change the issue of design patent obviousness as well as the perceived value of design patent protection. In preparation for the argument, this webinar will discuss an overview of the issues to be considered, a detailed dive into the United States’ brief and the amicus brief from Apple (both of which are expected to be important to the Court), and consideration of how this decision could affect the design patent obviousness question at the PTAB and the district court level in the future. The panel will also discuss details about what to expect during the oral argument. After the webinar, audience members will be armed with the knowledge they need to get the most out of the upcoming oral argument.

During this webinar, panelists will discuss the guidelines and potential consequences of the proposal. Under Bayh-Dole, universities and other contracting organizations are given rights to intellectual property generated from federally funded research and enabled to license these inventions to private sector partners who can then commercialize them. It includes a “march-in” provision that permits the government, in specific and limited circumstances, to require the patent holder to grant additional licenses to the patented technology.

A panel of highly experienced patent attorneys from the US, Europe and Japan will discuss recent court decisions on patent enablement, the impact for future decisions, and strategies for addressing enablement in patent applications and litigation. They will provide a brief overview of patent enablement in each country and discuss recent decisions including the US Supreme Court decision in Amgen and the Amgen cases in Europe and Japan. In addition, they will compare and contrast the patent enablement requirements for each country and provide strategies for complying with enablement.

It seems like every court and tribunal was active in altering the intellectual property landscape in 2023. The Supreme Court left its mark in patents, trademarks, and copyright in four important decisions. The Federal Circuit issued any number of informative and at times controversial opinions. The PTAB and TTAB were busy beavers and let’s not forget the regional circuits and their impact on trademarks and copyrights. Our panelists will attempt to distill down the past year’s major decisions and discuss the ones that will affect IP practitioners in 2024 and beyond.

A panel of highly experienced PTAB advocates will discuss some of the most significant developments in PTAB practice in 2023 and how those developments will impact future cases. They will discuss important decisions promulgated last year, including several designated precedential, as well as court treatment of PTAB decisions with implications for PTAB practice. In this discussion, you will hear what you need to know to keep your PTAB practice sharp in 2024.

This session will consider laws – such as the EU AI Act, EU Data Act, right to repair laws, TRIPS/WTO IP waiver, and privacy laws – that could compel owners of trade secrets to provide the otherwise secret information to governments, consumers and competing companies. Speakers will discuss increasingly restrictive government policies that limit the flow of information to certain nations (e.g., Chips and Science Act), and efforts to use trade laws and other mechanisms to penalize trade secret theft (e.g., Protecting Intellectual Property Act of 2022). In addition, this panel will also address the push in the US to reduce employee non-compete restrictions, which have the goal of increasing employee mobility but which make it harder for companies to protect trade secrets.

In this webinar, we will discuss the disparity in demographics of inventors, an overview of the Patent Pro Bono Program and its impact on inventor demographics, as well many other opportunities for low-resourced inventors through the USPTO’s Council on Inclusive Innovation and other programs. Patent Pro Bono Volunteers can share their skills and talents for intellectual property protection, while knowing that their clients have access to many resources for commercializing their invention.

Come listen to a lively discussion between a designer, a seasoned litigator and design patent prosecutor as they explore and consider various aspects of industrial design law including the ordinary observer, obviousness, indefiniteness, and the impact of other legal interpretations on industrial design rights. Hear the panel speak to how the law can advance the work of the industrial designer whose manufactured product is shaped to fit the people who use it as well as the processes that produce it – while striving to provide a distinctive elegance that attracts consumers to buy it.

This webinar will address Third-Party Preissuance Submissions under 35 U.S.C. 122(e) and how they can be strategically employed to curtail the issuance of overly broad US Patents. A case for when and how to take advantage of the power to participate in the patent prosecution of competitors will be laid out. Benefits vs. drawbacks and potential pitfalls will be outlined. Finally, a model third-party submission regime will be proposed, including publication monitoring, prior art development, and strategic drafting of third party submissions with be detailed. Presenters will include both in house and law firm counsel with extensive third-party submission experience to provide a diverse set of perspectives.